Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


German Authorities Stonewall Pharma’s Transparency Demands

This article was originally published in The Pink Sheet Daily

Executive Summary

Germany’s pharma industry is trying to force the government to reveal the decision-making process that led it to uphold the drug rebate and price freeze there, in the hope of avoiding fresh burdens in the future.


Related Content

German Pharma Industry Cries Foul As Preliminary Evaluation Of AMNOG Suggests It Works
Rasi At The EMA: Redefining Benefit/Risk As Staggered Approvals Rise
German Parliament Considers Lowering Mandatory Drug Rebate Level
Lacking "Mediator," EC Tightens Pharmacovigilance Proposals
Mediator Scandal Provokes Flurry of French Health Reforms But Impact Is Hard To Gauge Until The Dust Settles


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts